Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.42 |
| ▸ | XDH | P47989 | 1/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.40 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.40 |
| ▸ | IGF1R | P08069 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22693817 | 0.86 | ALDH1A3 (0.44) | FDPSALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL28801573 | 0.84 | FDPS (0.50) | FDPSALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL14747058 | 0.84 | ALDH1A1 (0.43) | FDPSALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL15331450 | 0.83 | ALDH1A1 (0.45) | FDPSALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL25327365 | 0.82 | FDPS (0.50) | FDPSALDH1A1SMN1; SMN2MAPTHTT | |
| SCHEMBL5448983 | 0.82 | FDPS (0.46) | FDPSALDH1A1SMN1; SMN2MAPTHTT | |
| SCHEMBL493460 | 0.81 | ALDH1A1 (0.60) | FDPSALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL16164351 | 0.81 | ALDH1A1 (0.40) | FDPSALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL4288561 | 0.81 | ALDH1A1 (0.60) | FDPSALDH1A1SMN1; SMN2RAB9ATSHR | |
| SCHEMBL1339632 | 0.81 | ALDH1A1 (0.50) | FDPSALDH1A1SMN1; SMN2MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114105881-B | Platelet aggregation inhibitor, and preparation method and application thereof | 沈阳海诺威医药科技有限公司 | 2024-01-26 | — | — | CN | disclosed |
| EP-3960734-B1 | PLATELET AGGREGATION INHIBITOR, PREPARATION AND USES THEREOF | SHENYANG HINEWY PHARMACEUTICAL TECH CO LTD (CN) | 2023-10-11 | — | — | EP | disclosed |
| US-11713300-B2 | Platelet aggregation inhibitor, preparation and uses thereof | SHENYANG HINEWY PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2023-08-01 | — | — | US | disclosed |
| CN-114105881-A | Platelet aggregation inhibitor and preparation method and application thereof | 沈阳海诺威医药科技有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-102766099-B | There is compound and salt, preparation method and the purposes of xanthine oxidase inhibitory activity | SHENYANG PHARMACEUTICAL UNIVERSITY (CN) | 2015-09-23 | — | — | CN | disclosed |
| CN-102766099-A | Compound with xanthine oxidase inhibitory activity as well as salt, preparation methods and application thereof | UNIV SHENYANG PHARMACEUTICAL | 2012-11-07 | — | — | CN | disclosed |
| WO-2010127212-A1 | INHIBITORS OF ACETYL-COA CARBOXYLASE | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2010-11-04 | — | — | WO | disclosed |
| US-20100280067-A1 | INHIBITORS OF ACETYL-COA CARBOXYLASE | SARMA PAKALA KUMARA SAVITHRU | 2010-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11713300-B2 | Platelet aggregation inhibitor, preparation and uses thereof | TFPI, F12, TFPI2 | FDPS 1870/4885ALDH1A1 1546/4885SMN1; SMN2 2498/4885 |
| US-20100280067-A1 | INHIBITORS OF ACETYL-COA CARBOXYLASE | ACACA, ACACB, PC | FDPS 116/4885ALDH1A1 276/4885SMN1; SMN2 4788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.